Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. point of care poc multi measurements testing
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Point Of Care Poc Multi Measurements Testing Articles & Analysis

50 news found

Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. These diagnostic services are designed to support the scientific community in identifying, understanding, and ultimately treating rare diseases that ...

ByProtheragen


CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries. Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including ...

ByCD Bioparticles


Medical Equipment Pump Solutions

Medical Equipment Pump Solutions

Medical Equipment Pump Solutions Industry Overview IVD, which stands for in vitro diagnostics, refers to products that conduct testing on samples taken from the human body (such as blood, body fluids, and tissues) outside of the body in order to obtain clinical diagnostic information. The IVD industry is subdivided into various sectors including immunodiagnostics, clinical chemistry, molecular ...

ByTops Industry & Technology Co.,Ltd.


Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development

Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has recently announced a series of new Anti-Small Molecule Label Antibodies to facilitate the development of nucleic acid lateral flow immunoassay (NALFIA). These antibodies can specifically bind to small molecule labels and offer customers multiple choices, including Anti Digoxin monoclonal ...

ByCreative Diagnostics


Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Today, the Baker-Polito Administration announced that more than $1.5 million has been awarded to four projects that seek to increase testing capacity and provide solutions for coronavirus testing. The funding is through the Accelerating Coronavirus Testing Solutions (A.C.T.S.) Program, designed and administered by the Massachusetts Life Sciences Center, which supports projects focused on two core ...

ByKephera Diagnostics, LLC


Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development Efforts

Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development Efforts

Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced today that the Company has entered a definitive agreement to acquire 100% of the share capital of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics (“LightDeck”), a pioneer in innovative planar waveguide ...

ByLightDeck Diagnostics


HiberGene Diagnostics introduces brand new UK division at NEQAS event

HiberGene Diagnostics introduces brand new UK division at NEQAS event

HiberGene Diagnostics, the leading manufacturer of molecular diagnostics products in Ireland, is pleased to announce that it will supply its innovative point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland. These high-quality testing solutions cover infectious and transmissible disease areas – including respiratory, sexually ...

ByHiberGene Diagnostics


Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results

The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border. CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit. Chiricahua Community Health Centers, Inc. (CCHCI) today announced a collaboration ...

ByVisby Medical, Inc.


Major clinical study shows Virusight’s SpectraLIT instantly detects COVID-19 with 96.3% accuracy

Major clinical study shows Virusight’s SpectraLIT instantly detects COVID-19 with 96.3% accuracy

Virusight Diagnostic, a world leader in combining artificial intelligence software and spectral technology today announced the results of a major clinical study that found its ultra-rapid, point of care Pathogens Diagnostic solution consistently delivers 96.3% accuracy when compared to the gold standard RT-PCR. The study was conducted by the Department of Science and Technology, University of ...

ByVirusight


Anavasi Diagnostics Announces FDA EUA Submission for Its COVID-19 Test

Anavasi Diagnostics Announces FDA EUA Submission for Its COVID-19 Test

Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). Anavasi is a medical technology company focused on the development of novel molecular diagnostic testing. It uses a ...

ByAnavasi Diagnostics


How portable diagnostic readers are changing the future for patient care

How portable diagnostic readers are changing the future for patient care

There are numerous ways to provide quality diagnosis and preventative care. One of them is by investing in portable scanners, adopting huge benefits for improved healthcare procedures. What is a portable diagnostic reader? Usually a handheld device, measuring health parameters and helping to diagnose a patient using smart algorithms from a chosen assay. At AgPlus, The Agilis Reader works in ...

ByAgPlus Diagnostics Ltd


LightDeck Diagnostics Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

LightDeck Diagnostics Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. This year’s list honors businesses that are making the biggest impact on their industries and culture as a whole—ultimately thriving in ...

ByLightDeck Diagnostics


LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Department of Defense (DoD). The funds will be used to develop a rapid, quantitative, multiplexed test for ...

ByLightDeck Diagnostics


Quidel Announces Preliminary Revenue for Fourth Quarter 2021

Quidel Announces Preliminary Revenue for Fourth Quarter 2021

Quidel Corporation (NASDAQ: QDEL) (“Quidel”),a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects total revenues in the fourth quarter of 2021 to be in the range of $633 million to $637 million and full year total revenues to be in the range of $1,695 million to $1,699 million. COVID-19 ...

ByQuidel Corporation


TearLab Corporation Announces Adam Szaronos as President and Chief Executive Officer, and Jim Mazzo as Executive Chairman of the Board

TearLab Corporation Announces Adam Szaronos as President and Chief Executive Officer, and Jim Mazzo as Executive Chairman of the Board

TearLab Corporation, a global ophthalmic diagnostics company marketing point-of-care laboratory testing, today announced that Adam Szaronos has been appointed President and Chief Executive Officer by the company's Board of Directors, effective immediately. Mr. Szaronos has been instrumental in leading teams and bringing innovations to market to address unmet needs throughout eye care. Mr. ...

BySOFIE


EIB backs Belgian rapid COVID-19 PCR Test developer miDiagnostics

EIB backs Belgian rapid COVID-19 PCR Test developer miDiagnostics

miDiagnostics has been granted a €20 million loan from European Investment Bank to scale up its research and development activities and accelerate the market launch of its diagnostics solution. With EU backing, the EIB financing will strengthen home-grown European technology that can play an important role in helping to bring the pandemic under control. The transaction is supported by ...

BymiDIAGNOSTICS


Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association

Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association

Visby Medical™, a leading medical diagnostic company, today announced results from the cross-sectional single visit patient outcomes and implementation study, which evaluated self-collected vaginal swab samples from 55 women using the Visby Medical Sexual Health Click Test for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). The results of this ...

ByVisby Medical, Inc.


New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability

New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability

Anavasi Diagnostics, a medical technology company focused on the development of novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology, today announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative. The funding will accelerate the launch and broad market ...

ByAnavasi Diagnostics


CEO Nick Traggis is working to scale manufacturing as the healthcare market demands faster point-of-care diagnostics.

CEO Nick Traggis is working to scale manufacturing as the healthcare market demands faster point-of-care diagnostics.

Traggis started working with LightDeck Diagnostics founder Chris Myatt at a previous endeavor, Precision Photonics, a Boulder-based manufacturer of laser optics, in the early 2000s. Originally named MBio Diagnostics, LightDeck began as a “skunkworks effort” inside Precision. “I ended up taking over the reins there at Precision Photonics around the time Chris started focusing ...

ByLightDeck Diagnostics


Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™ SARS-CoV-2 Rapid Antigen Test. The CoviDx test gives qualified healthcare providers qualitative, easy-to-interpret results within 15-20 minutes in cases of suspected COVID-19 and when performing serial ...

ByLumos Diagnostics

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT